Product |
Description |
Discovery Preclinical Clinical |
PNA *HBV Treatment
|
anti-Hepatitis B drug (a potential Category 1 drug)
|
|
| |
new immuno-enhancer drug (a potential Category 1 drug) and alternative drug to cancer treatment
|
|
YC-12
|
Oxazolidinone Antibiotics (a potential Category 1 drug), a drug that is more effective against a broad spectrum of bacterial pathogens, especially Gram-positive drug-resistant bacteria
|
|
CO-8
|
A new drug for the treatment of diabetes
|
|
CO-12
|
A more effective drug for the treatment of drug-resistant tuberculosis
|
|
CO-18
|
An anti-obesity drug used to reduce the risk of cardiovascular disease, metabolic syndrome, high cholesterol and diabetes
|
|